// IP Marketing video - START// IP Marketing video - END

VivaCell-MTS boosts development of neonatal health care in Armenia

VivaCell-MTS boosts development of neonatal health care in Armenia

PanARMENIAN.Net - VivaCell-MTS and BirthLink have been cooperating for already 8 years now, aiming to reduce neonatal mortality and morbidity by supporting the care of sick and premature babies in Armenia. Since the start of the project, VivaCell-MTS has allocated some AMD 600 million to equip forty-three hospitals in Yerevan and the provinces.

Following the 2000 Millennium Development Goal to reduce child mortality by 2015, WHO states there is an unfinished agenda for Women and Children’s health, with newborn deaths still accounting for 44% of under-five deaths globally. Cost-effective solutions are now available to protect women and children on the day of birth: 80% of newborn deaths are caused by preventable and treatable conditions.

VivaCell-MTS will host neonatologists from maternity hospitals of the provinces and Yerevan for two days, who will be trained to achieve quality improvement, national standards of care. At the seminar, a new Neonatal Database program that enables monitoring all babies requiring intensive care after birth will be introduced.

VivaCell-MTS General Manager Ralph Yirikian, the Chief Neonatologist of Armenia Pavel Mazmanyan and the Director of BirthLink Kathy Mellor welcomed the neonatologists at the beginning of the seminar.

 Top stories
62% of Armenians have a positive image of the European Union (EU), compared to 48% in 2018, the survey says.
The government on Thursday, June 27 approved a draft law on raising minimum wage in Armenia by 23.6%
Armenia’s population will dwindle to a little more than 2 million in 2100 from today’s almost three million.
Nikol Pashinyan has said that Armenia badly needs a truly independent and impartial judicial system.
Partner news